Skip to main content

No significant change in total healthcare costs with aripiprazole lauroxil

This is a preview of subscription content, access via your institution.

Notes

  1. 2017 US dollars

Reference

  • Lauriello J, et al. Real-World Outcomes and Costs Following 6 Months of Treatment with the Long-Acting Injectable (LAI) Aripiprazole Lauroxil for the Treatment of Schizophrenia CNS Drugs : 21 Sep 2021. Available from: URL: https://doi.org/10.1007/s40263-021-00849-2

Download references

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

No significant change in total healthcare costs with aripiprazole lauroxil. PharmacoEcon Outcomes News 888, 22 (2021). https://doi.org/10.1007/s40274-021-08072-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-08072-x